Reducing the risk of breast cancer

Written by: Professor Kefah Mokbel
Published:
Edited by: Robert Smith

By now you should know that breast cancer is one of the most common forms of cancer in the UK. Although breast cancer survival rate is improving, it’s important to implement a range of lifestyle habits to prevent it.

Luckily, extremely experienced Professor Kefah Mokbel, spoke to us about how breast cancer can be prevented. He is one of the UK’s leading oncoplastic breast surgeons.

How can breast cancer be prevented?

The risk of developing breast cancer can be reduced with a range of measures:

  • Avoid becoming overweight after the menopause.
  • Take vitamin D3 supplements or expose your skin to adequate sunshine
  • Undertake regular exercise/physical activity. One hour per week should be sufficient.
  • Avoid excessive alcohol intake, try not to drink more than 6 units of alcohol per week.
  • Reduce the intake of red meat and animal fat (esp. overcooked red meat).
  • Eat more fish.
  • Replace low-fat dairy products with full-fat dairy products.
  • Increase the intake of vegetables and fresh fruits especially: raspberries, cranberries, red grapes, cherries, and pomegranates. These fruits can be taken as fresh juice drinks with no added artificial ingredients (e.g. fresh smoothies).
  • Increase the amount of green tea you consume.
  • Increase the amount of olive oil you have.
  • Add turmeric, red chilies and black pepper to diet
  • Consider taking Omega3, vitamin B6 and lactobacillus acidophilus supplements

It's worth mentioning that there is no credible scientific evidence that low-fat dairy products or underarm cosmetics increase the risk of developing breast cancer. Soya products appear to be neutral i.e. they cause neither benefit nor harm when it comes to breast cancer.

 

Hormonal

Use the safest preparations or alternatives to HRT and avoid taking HRT after the menopause.

Try to have your child before the age of 30 years and avoid pregnancy after the age of 40 years.

 

Other ways (for women at high risk)

Anti-oestrogen drugs, such as tamoxifen and raloxifene (used to prevent osteoporosis in post-menopausal women) can reduce the risk of breast cancer by 50–75% in women at above average risk. Tamoxifen can be taken at a low dose like 5 mg for prevention with minimal side effects.

Preventative mastectomy seems to reduce the risk of breast cancer by 90% in high-risk women, for example, in those who carry breast cancer genes such as BRCAI, BRCA2 and PALB2. Figure 1 demonstrates the outcome of double mastectomy and reconstruction using implants in a BRCA 2 gene carrier performed by Professor Kefah Mokbel.

Figure 1 demonstrates the outcome of double mastectomy and reconstruction using nano-textured implants (pre-pec plus mesh) in a BRCA 2 gene carrier performed by Professor Kefah Mokbel

Oophorectomy also decreases the risk of developing breast cancer in those who are BRCA-1 and BRCA-2 gene carriers in addition to reducing the risk of ovarian cancer.

Recent research suggests that aspirin-like drugs, metformin and statins may reduce the risk of developing breast cancer. However, further research is needed to confirm that these drugs can be recommended for breast cancer prevention.

Drugs that inhibit oestrogen production by peripheral tissue known as aromatase inhibitors have also been found to be better than tamoxifen in preventing breast cancer is the opposite breast among postmenopausal women who have breast cancer. However, further research is needed.

 

What's the purpose of a breast screening?

Breast screening is used to try and detect breast cancer at an early stage in women who appear well and who may not have any symptoms. The earlier it is detected, the more likely it is to be treatable.

 

What are some of the available screening methods available?

Screening methods include:

  • 3D digital mammography and/or ultrasound scan
  • Magnetic resonance imaging (MRI) for high risk patients

 

If you feel you require screening or you would like to prevent breast cancer, you may like to book an appointment with an oncoplastic breast surgeon. Visit Professor Kefah Mokbel’s profile today for more information.

By Professor Kefah Mokbel
Surgery

Professor Kefah Mokbel is an internationally renowned breast cancer surgeon and researcher who specialises in the multidisciplinary care of patients with breast cancer. He is the lead oncoplastic breast surgeon at the London Breast Institute. His areas of expertise include breast cancer detection, oncoplastic breast surgery, breast screening, breast cysts and lumps and breast implants. In addition, he is an honorary professor of breast cancer surgery at Brunel University London and the founder and president of a UK cancer charity; Breast Cancer Hope.

Following the completion of his undergraduate medical education at the London Hospital Medical College in 1990, Professor Mokbel pursued surgical training at the Royal Marsden, Charing Cross, Chelsea and Westminster, Saint Mary’s and St Bartholomew’s hospitals and completed his higher surgical training as an oncoplastic breast surgeon in 2000. Professer Mokbel has won various prestigious prizes, awards and honours during his educatiom, training and postgraduate career. 

He qualified as a Fellow of the Royal College of Surgeons in 1994 and was then granted the Master of Surgery degree in 2000 by The Imperial College of Science, Technology and Medicine for his research in the field of molecular biology of breast cancer.

Professor Mokbel's research interest lies in the field of molecular biology and the clinical management of breast cancer and aesthetic breast surgery. This includes breast reconstruction following mastectomy and augmentation mammoplasty using implants and fat transfer. In addition, he has authored or coauthored more than 400 scientific papers, editorials, commentaries and textbook chapters (Google Scholar H-index = 51 and I10-index = 170) and has authored 14 textbooks aimed at medical students and postgraduate doctors. His current academic interest is focused on how to apply the advances from clinical trials to daily surgical practice. He is also currently a member of the editorial board of various global medical journals and has peer-reviewed for renowned journals such as The Lancet. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Laser
    Laser scar therapy
    Surgical dermatology
    Hair transplant
    Scar revision
    Hyperhidrosis
    Facial surgery
    Chin surgery (mentoplasty)
    Breast augmentation with implants
    Breast fat transfer
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.